2019 Supplier Spotlight

A panel of experts examines how stakeholders can support strategies that improve patient outcomes, while also navigating various distribution models.

Tracy Lopez uncovers the fundamentals pertaining to third-party logistics providers.

The company’s branded form of nadofaragene firadenovec-vncg will also be produced at a hub in Parsippany, NJ.

Donald Prentiss discusses the value of these pharmacies, especially during shortages.

The Carlsbad plant is expected to accelerate both the development and commercialization of cell therapies.

The new firm—with 13 manufacturing facilities spanning France, Sweden, and Spain—will support the pharma supply chain through to commercialization.